Tempus AI (TEM) EV/FCF: History & Chart

Tempus AI, Inc.(TEM)

Medical - Healthcare Information Services · Chicago, IL

$60.12-1.16 (-1.89%)

Delayed quote: Sep 10, 2026, 10:15 AM EDT

About Tempus AI, Inc.

Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests. The company also provides Lens, a software application for life sciences and advanced precision research; diagnostics services, such as NGS diagnostics, PCR profiling, and other anatomic and molecular pathology tests; and large-panel solid tumor and hematologic testing through multiple assays, with its core clinical assay (xT and xR) offering large panel DNA, RNA full transcriptome, and incidental germline findings through normal blood or saliva analyses. In addition, it provides genetic tests focused on inherited conditions; an nP assay for pharmacogenomic testing for patients with psychiatric conditions, including depression, general anxiety disorder, bipolar disorder, and other relevant diagnoses; Insights, which licenses libraries of linked, de-identified clinical, molecular, and imaging data; Organoids, a tumor derived biological modeling. Further, the company offers Trials for clinical trial matching services; Next, an AI platform; Algos, an algorithm-based diagnostics application. It has Strategic Collaborations with AstraZeneca AB, Pathos AI, Inc., GlaxoSmithKline, Merck, and Recursion Pharmaceuticals, Inc. Additionally, it also has a strategic collaboration with Blood Cancer United to develop registry for pediatric acute myeloid leukemia. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.

Chicago, IL

3,800 employees

www.tempus.com

Healthcare / Medical - Healthcare Information Services

Sector: Healthcare
Industry: Medical - Healthcare Information Services
CEO: Eric Lefkofsky

View full financials

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
Tempus AI, Inc. (TEM)	$10.53B	N/A	N/A	N/A	N/A
Molina Healthcare, Inc. (MOH)vs ›	$10.53B	35.32x	31.63x	46.15x	30.28x
Universal Health Services, Inc. (UHS)vs ›	$10.52B	18.92x	19.25x	23.22x	57.77x
The Cooper Companies, Inc. (COO)vs ›	$10.64B	N/A	35.84x	79.44x	64.94x
Align Technology, Inc. (ALGN)vs ›	$10.71B	17.34x	17.20x	26.74x	36.52x
The Ensign Group, Inc. (ENSG)vs ›	$10.09B	28.82x	37.75x	40.09x	35.71x
Bio-Rad Laboratories, Inc. (BIO)vs ›	$10.06B	30.45x	25.86x	38.17x	50.56x
Globus Medical, Inc. (GMED)vs ›	$9.99B	12.78x	18.45x	33.52x	36.89x
Henry Schein, Inc. (HSIC)vs ›	$9.97B	25.28x	29.14x	26.85x	24.39x
Bio-Techne Corporation (TECH)vs ›	$11.32B	43.08x	39.74x	44.77x	48.64x

NAME

MARKET CAP

EV/FCF RATIO

TTM

Tempus AI, Inc. (TEM)

$10.53B

N/A

Molina Healthcare, Inc. (MOH)vs ›

$10.53B

35.32x

31.63x

46.15x

30.28x

Universal Health Services, Inc. (UHS)vs ›

$10.52B

18.92x

19.25x

23.22x

57.77x

The Cooper Companies, Inc. (COO)vs ›

$10.64B

N/A

35.84x

79.44x

64.94x

Align Technology, Inc. (ALGN)vs ›

$10.71B

17.34x

17.20x

26.74x

36.52x

The Ensign Group, Inc. (ENSG)vs ›

$10.09B

28.82x

37.75x

40.09x

35.71x

Bio-Rad Laboratories, Inc. (BIO)vs ›

$10.06B

30.45x

25.86x

38.17x

50.56x

Globus Medical, Inc. (GMED)vs ›

$9.99B

12.78x

18.45x

33.52x

36.89x

Henry Schein, Inc. (HSIC)vs ›

$9.97B

25.28x

29.14x

26.85x

24.39x

Bio-Techne Corporation (TECH)vs ›

$11.32B

43.08x

39.74x

44.77x

48.64x

EV/FCF Ratio: N/A

TEM EV/FCF Ratio Metrics

TEM Competitors' EV/FCF Ratio

Cash Flow Valuation Comparison

EV/FCF Ratio Formula & Definition

Related Metrics